Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

205 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Completed

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

NCT02250560

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • North Hampshire Haemophilia Centre, Uplands House, North Hampshire Hospital, Aldermaston Road Basingstoke, United Kingdom
  • Haemophilia Centre, The Royal London Hospital, White Chapel London, United Kingdom
  • Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, Pond Street London, United Kingdom
  • Manchester Thrombosis and Haemostasis Centre, University of Manchester, Department of Haematology, Manchester Royal Infirmary, Oxford Road Manchester, United Kingdom
View Trial Details
Completed

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

NCT01386528

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
View all 41 locations
View Trial Details
Completed

Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients

NCT01333111

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
View all 43 locations
View Trial Details
Completed

Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China

NCT02336178

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 16 locations
View Trial Details
Completed

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

NCT00486278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 45 locations
View Trial Details
Completed

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

NCT00956345

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Cincinnati, Ohio, United States
  • Novo Nordisk Investigational Site Portland, Oregon, United States
  • Novo Nordisk Investigational Site Richmond, Virginia, United States
  • Novo Nordisk Investigational Site Copenhagen, Denmark
View all 19 locations
View Trial Details

Related conditions